MedPath

Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease

Not Applicable
Recruiting
Conditions
Freezing of Gait
Parkinson Disease
Registration Number
NCT06147713
Lead Sponsor
Xuanwu Hospital, Beijing
Brief Summary

Freezing of gait (FOG) is a common, disabling symptom of later stage Parkinson's disease (PD), and can induce significant morbidity and mortality by increasing risk of falls as the disease progresses. Despite optimum medical management and deep brain stimulation therapy, many patients with PD are incapacitated by FOG and gait disorders. Non-invasive vibrotactile stimulation has been reported to potentially improve FOG of patients with PD. However, results of studies were variable, and there is a lack of convenient vibrotactile devices ready for daily use with reliable clinical trial data. In the proposed study, the investigator will test the effect of a newly developed vibrotactile foot device (Smart shoe) on participants diagnosed with PD and FOG. EEG and fMRI are obtained in order to investigate the underlying neurological mechanism.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age 30-80 years
  • Diagnosed with Parkinson's Disease according to MDS Clinical Diagnostic Criteria
  • Stable drug therapy without any change in the past one month
  • Subjective presence of FOG more than once per day
  • Objective presence of FOG by provoking tasks, e.g., gait initiation, rapid full turn, et al.
  • Able to walk unaided at least 20 meters
  • Provide written informed consent
Exclusion Criteria
  • Stroke and other diseases interfering ambulation
  • Severe foot sensory impairments disabling the individual to perceive vibratory stimulation
  • History of deep brain stimulation surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
New Freezing of Gait Questionnaire (NFOGQ)2 weeks

Changes in the New Freezing of Gait Questionnaire (NFOGQ) score

Freezing severity2 weeks

Changes in the quantified freezing severity during walking task, videotape reviewed by movement disorder specialists

Secondary Outcome Measures
NameTimeMethod
Quantitative Gait parameters2 weeks

Changes in gait parameters such as stride length, et al. during walking tasks

Number of falls and near falls2 weeks

Changes in number of falls and near falls during intervention period

Berg Balance Scale2 weeks

Changes in the Berg Balance Scale score

Clinical Global Impressions Scale (CGI-I)2 weeks

Changes in the Clinical Global Impressions Scale (CGI-I) score

39-item Parkinson's Disease Questionnaire (PDQ-39)2 weeks

Changes in the 39-item Parkinson's Disease Questionnaire (PDQ-39) score

MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III2 weeks

Changes in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III score

Trial Locations

Locations (1)

Xuanwu Hospital

🇨🇳

Beijing, China

Xuanwu Hospital
🇨🇳Beijing, China
Piu Chan, MD.,PhD.
Contact
+86-010-83198677
pbchan@hotmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.